AHS 2022
Presenting at AHS 2022, researchers determined the effect of generalized anxiety disorder on the responsiveness of BoNT-A treatment from pediatric patients with chronic migraine.
AAN 2022
In a global, phase 3 trial, researchers evaluated the efficacy of ganaxolone as an adjunctive treatment compared to placebo for major motor seizures in patients with CDKL5 deficiency disorder.
AAN 2022
Researchers sought to establish whether frequent use of a combined biofeedback-virtual reality device is associated with improvements in chronic migraine, especially in patients refractory to pharmacotherapy.
MDS 2021
In a study presented at MDS 2021, researchers assessed whether patients with tic disorders with or without major psychoses were at risk of developing tardive dyskinesia.
CMSC 2019 Coverage
Age- and sex-stratified comorbidity and concomitant medication use has been found among individuals with MS who have newly initiated disease-modifying drugs.
AAIC 2018
Currently, there are no US consensus on best clinical practice guidelines that incorporate multispecialty recommendations for evaluating cognitive impairment that are thought to be due to Alzheimer's disease and Related Dementias (ADRD) for use by physicians and nurse practitioners.
AAN 2018 Coverage
Researchers sought to assess outcomes in hospitalized patients with comorbid Parkinson disease and major depressive disorder following administration of deep brain stimulation.
AES 2017
Researchers examined whether there are clinical features or treatments associated with neuropsychiatric outcomes in BECTS.
AHS 2017
Concordance or discordance in pain catastrophizing between parents and children may impact pain coping in children with migraine.
AHS 2017
NINDS program director urged clinicians, researchers, and clinician-scientists to submit grant applications to the NIH, as very few are submitted in the field of migraine and headache research.
